Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Propanc Biopharma, Inc. PPCB NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • AU • USD

SharesGrow Score
28/100
0/4 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Analyst Consensus — PPCB

No analyst consensus data available for PPCB.

People Also View

KRYS
KRYS
Krystal Biotech, Inc.
$270.00
+0.97%
 RETA
RETA
Reata Pharmaceuticals, Inc.
$172.36
+0.02%
 VIR
VIR
Vir Biotechnology, Inc.
$10.05
+7.95%
 CVAC
CVAC
CureVac N.V.
$4.66
+0.00%
 ZURA
ZURA
Zura Bio Limited
$5.72
+0.70%
 ELEV
ELEV
Elevation Oncology, Inc.
$0.37
-2.12%
 AVRO
AVRO
AVROBIO, Inc.
$1.40
-1.41%
 CWBR
CWBR
CohBar, Inc.
$0.41
+0.00%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message